Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-19 Sale |
2023-04-20 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
1,290 | $1.272 | $1,641 | 83,663 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-19 4:58 pm |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
6,347 | $6.996 | $44,404 | 64,453 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-03-17 5:15 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
425,000 | $0 | 608,663 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:33 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
250,000 | $0 | 333,663 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 09:23 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
107,400 | $0 | 171,853 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:47 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
52,000 | $0 | 52,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-28 5:07 pm |
N/A 2032-01-27 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
171,250 | $0 | 171,250 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 4:17 pm |
N/A 2031-05-03 |
Trillium Therapeutics Inc. | TRIL | Looker Benjamin General Counsel |
190,000 | $0 | 190,000 (Direct) |
View |